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INTRODUCTION
Studies have found that portal hypertension may
cause gastrointestinal complications like esophageal
varices, gastric varices, portal hypertensive
gastroenterocolopathy, hemorrhoids, etc.1-16 Portal
hypertensive enteropathy could cause gastrointestinal
symptoms including chronic diarrhea, bleeding, Small
Intestine Bacterial Overgrowth (SIBO).1-16,17,18
Some studies found that the capillary vessels of
the small intestinal mucosa had a wider diameter and
that the wall was thicker than normal.1,3,19 This study
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ABSTRACT
Background/Aim: Some studies found that portal hypertension cause complication such as portal
hypertensive gastroenterocolopathy. This study was done to find any abnormalities in the small intestinal
mucosa and villi of the portal hypertensive patients.
Method: Thirty patients with liver cirrhosis, portal hypertension and esophageal varices between
2000 - 2001 were included in this study. A duodenoscopic examination was performed to determine any
abnormalities. Biopsy specimens were taken from the descending part of duodenum and the duodenal
bulb for histopathological examination. The findings were compared to 37 functional dyspepsia patients.
Result: In the duodenal bulb and descending part of duodenum: the width of the villous  of the portal
hypertensive group was larger than the control (p < 0.001), the diameter of the mucosal villous vessel was
larger than in the control (p < 0.001) and the thickness of the mucosal villous vessel wall was thicker than
in the control (p < 0.001).
Conclusion: There were abnormalities of the mucosa in portal hypertensive enteropathy patients
including the mucosal vessel diameter, wall thickness, number of goblet cells.
Keywords: portal hypertensive enteropathy, liver cirrhosis
was conducted to uncover any abnormalities in the small
intestinal mucosa and villi of portal hypertensive
patients.
METHODS
Thirty patients with cirrhosis of the liver and portal
hypertension and esophageal varices who came to
the clinic between 2000 and 2001 were included in this
study. The patients were seen as in and out patients of
the Division of Gastroenterology and Hepatology
Department of Internal Medicine Cipto Mangunkusumo
hospital, Indonesia. A duodenoscopic examination was
performed on each of the patients to determine any
abnormalities. Blood coagulation tests were performed
before duodenoscopy. We used the Olympus PCF-10
pediatric colonoscope for the examination. Biopsy
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specimens were taken from the descending part of 
the duodenum (2 specimens) and the duodenal bulb  
(2 specimens), and histopathological examination was  
performed. Patients were excluded if they were  
uncooperative, had no esophageal varices, the blood  
coagulation result exceeded 2 x normal, had DIC and  
other hemostatic abnormalities, or had active bleeding.  
 The diagnosis of liver cirrhosis will be supported by  
ultrasonography examination. The liver function was  
graded as A, B and C according to Child-Pugh criteria  
(table 1).20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The endoscopical appearances of gastric mucosa  
in portal hypertensive gastropathy was graded  
according to the OMED and Indonesian grading  
system. The grade of portal hypertensive gastropathy  
was mild, moderate and severe. Mild if we found  
mosaic pattern appearance, mild hyperemia, and small  
vascular lesions (small red color sign or red dot) less  
than 10. Moderate if we found mosaic pattern  
appearance, moderate hyperemia, and 10-20 small  
vascular lesions. Severe if we found mosaic pattern  
appearance, severe hyperemia, more than 20 small  
vascular lesions, cherry red spots,  black brown spots  
and ulcer.21-24 The endoscopical appearances of  
duodenal mucosa in portal hypertensive enteropathy  
was graded according to the Indonesian grading  
system. The grade of portal hypertensive enteropathy  
was mild, moderate and severe. Mild if we found mild  
hyperemia, and less than 10 small vascular lesions  
(small red color sign or red dot). Moderate if we found  
moderate hyperemia, and 10-20 small vascular lesions.  
Severe if we found   severe hyperemia, more than  
20 small vascular lesions, cherry red spots, black brown  
spots and ulcer. Hyperemia if there was an increased  
vascularity with red mucosa.23 Vascular lesion  
(angiectasia) was a red structure of different small sizes  
and shapes-point, claw, spider, cobweb-due to  
vascular malformation. It can be single or multiple.  
Mosaic pattern appearance was multiple erythematous  
areas outlined by a white reticular network. Cherry 
red spots were confluent areas of diffuse bleeding. 
Black brown spots were diffuse dark points and spots 
due to subepithelial hematin deposits. Ulcer implies a 
benign defect of the gastro intestinal mucosa, which is 
larger and deeper than erosion. 
The esophageal varices were graded into grade  
I-IV according to the OMED criteria, in a maximally  
relaxed esophagus.23 Grade 1 if there was hardly  
noticeable protrusion, visible with a valsalva  
maneuver. Grade 2 if the protrusion of varices was up  
to 1/4 of the esophageal lumen. Grade 3 if 
the protrusion of varices was up to 1/2 of the esoph- 
ageal lumen. Grade 4 if the protrusion of varices was 
greater than 1/2 of the esophageal lumen. 
On histopathology, we counted the maximum  
diameter of the vessel and thickness of vessel wall in  
duodeno-jejunal villi, the height, width of the villous  
mucosa and the intervillous space of the duodeno- 
jejunal villi. The findings were then compared to  
the data of 37 functional dyspepsia patients without  
upper gastrointestinal abnormality (endoscopy and  
histopathology). The measurements of the mucosa  
were performed with micrometer and microscope with  
objective 10 x 10, 10 x 40 and 10 x 100. In magnifying  
10 x 10 : 1 U = 10 micrometer and 10 x 40 : 1U = 2.5  
micrometer. Haematoxyllin-Eosin was used for  
the histopathological staining. A scoring system for  
inflammatory cells (lymphocytes, plasma cells,  
eosinophils and polymorphonuclear cells) was used as  
follows: 0 (negative), +, ++ +++. + if the histology  
showed that the distance between 2 cells was larger  
than the diameter of the cells. ++ if the histology showed  
that the distance between 2 inflammatory cells was  
smaller than the diameter of the cells. +++ if  
the inflammatory cells were touching each other.  
The number of goblet cells in 100 mm were measured  
in all specimens. The data were analyzed with ANOVA  
and Chi-square/Fischer tests. 
RESULTS 
The most frequent characteristics of the patients 
were age 50.55 ± 11.62 years old, male (62.5%), 
Child C functional status (55.0%), dyspepsia symptom 
(47.5%), grade III esophageal varices (50%). 
Diarrhea was seen in two patients (table 2). 
We found 100% abnormalities in the stomach which  
we called portal hypertensive gastropathy. The portal  
hypertensive enteropathy was found in the duodenal  
bulb (24 of 40 patients/60%) and in the descending  
part of duodenum (23 of 40 patients 57.5%) ( table 3).  
 From the histopathological examination in  
the duodenal bulb, we found that the diameter and wall  
thickness of the mucosal villi vessels were larger in  
the portal hypertension group than in the control group  
(p < 0.001) (table 4).  
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Table 1. Child Pugh criteria 
Variable 1 2 3 
Ascites No Mild Severe 
Encephalopathy No 1-2 3- 4 
Total bilirubin (mg/dL) < 2 2- 3 > 3 
Serum albumin (g/dL) > 3.5 2.8- 3.5 < 2.8 
Prothrombin time (sec) < 16 17 - 21 > 22 
Total Pugh Score 
< 6 
7 - 9 
10 – 15 
Child class 
A 
B 
C 
  
Cited from Pugh RNH, et al. Br J Surg 1973.20 
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Table 2. Characteristics of the portal hypertensive patients 
Characteristics Frequency  (n = 40) Percent (%) 
Mean age (years old) 50.55 ± 11.62  
Sex 
Male : female 25:15 62.5 : 37.5 
Child 
A 
B 
C 
4 
14 
22 
10.0 
35.0 
55.0 
Symptom 
Dyspepsia 19/40 47.5  
Diarrhea 2/40 5 
Diarrhea 
 Stool form: soft nonbloody-non steatorrhea 
 watery 
1 
1 
 
 Duration:   4 weeks 
                 7 weeks 
1 
1 
 
Grade of esophageal varices 
 I 1 2.5 
 II 8 20.0 
 III 20 50.0 
 IV 11 27.5 
 
Table 3. Endoscopical appearances of portal hypertensive gastro-duodenopathy 
Location of 
abnormality 
Grade of 
hyperemia 
Grade of vascular 
lesion/ red color 
sign 
Ulcer 
(Yes/No) 
Mozaic 
pattern 
(Yes/No) 
Overall grade of  
gastro- 
duodenopathy 
Normal  0 Normal 0 Normal 0 
Mild     2 Mild     3 Mild     2 
Mod    35 Mod     34 Mod     35 
Stomach 
Severe  3 Severe   3 
No  37 
Yes  3 
No   0 
Yes 40 
Severe  3 
Normal  16 Normal 17 Normal 16 
Mild     14 Mild      13 Mild     12 
Mod    10 Mod     10 Mod     5 
Duodenal bulb 
Severe 0 Severe 0 
No  33 
Yes  7 
No  40 
Yes  0 
Severe  7 
Normal  18 Normal 21 Normal 17 
Mild     13 Mild     11 Mild     12 
Mod    8 Mod     8 Mod     6 
Pars 
descendens 
duodenum 
Severe  1 Severe  0 
No  36 
Yes  4 
No  40 
Yes  0 
Severe  5 
 
Table 4. Histopathologic mucosal measurement in the duodenal bulb of the patients 
Mucosal measurement (means) Portal hypertension Control p value 
Villous height (m) 266.81 ±  69.16 265.00 ± 81.89 ns* 
Crypt height (m) 221.18 ± 65.23 196.67 ±   56.01 ns* 
Villous width (m) 132.5 ± 36.71 96.00 ± 27.46 < 0.001* 
Intervillous space (m) 47.87 ±  24.30 59.14 ±  74.14 ns* 
Crypt: villous ratio 0.86 ±  0.29 0.80 ±  0.26 ns* 
Goblet cells in 100 (m) villous height 3.73 ±  1.32 2.95 ± 1.41 0.026* 
Vessels in the top of the villi 
 Diameter (m) 
 Wall thickness (m) 
 
26.31 ±  11.71 
2.26 ±  0.60 
 
12.35 ±  4.73 
0.81 ±  0.36 
 
< 0.001* 
< 0.001* 
Vessels in the base of the villi 
 Diameter (m) 
 Wall thickness (m) 
 
22.12 ±  10.18 
2.07 ±  0.54 
 
14.07 ±  7.22 
0.76 ± 0.39 
 
< 0.001* 
< 0.001* 
*Anova/Kruskal Wallis test;    ns = not significant 
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From  histopathological  examinations  in 
the descending part of duodenum, we found that 
the diameter and wall thickness of the mucosal villi 
vessels were larger in the portal hypertension group 
than in the control group (p < 0.001) (table 5). 
In the duodenal bulb, the lymphocyte infiltration,  
polymorphonuclear cell infiltration and stage of  
inflammation were more prominent in the control group  
than in the portal hypertension group. In the  
descending part of duodenum, the lymphocyte  
infiltration,polymorphonuclear cell infiltration and stage  
of inflammation were more prominent (increased) in  
the portal hypertension group than in the control group  
(table 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The mean age of portal hypertension patients in this 
study (50.55 ± 11.62) was the same as in another study 
in portal hypertensive gastropathy patients.6 Most 
patients in this study were male, the same as in 
the other study.6 
There were 47.5% of the portal hypertension 
patients complaining of dyspepsia and 5% had chronic 
diarrhea. These symptoms were different from those 
found in other studies.6,7 
Child C function status was the most frequent  
finding in this study. This was the same as in other  
studies.6,7 Two patients were complaining of chronic  
diarhea, this symptom could be due to small intestinal  
bacterial overgrowth, intestine mucosal abnormalities  
due to portal hypertension, maldigestion, etc.18,25,26  
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Table 5. Histopathologic mucosal measurement in descending part of duodenum of the patients 
Mucosal measurement (means) Portal hypertension (n = 40) 
Control 
(n = 37) p value 
Villous height (m)  266.62 ±  64,93 317.27 ±  99.66 0.018* 
Crypt height (m)  209.16 ±  65.52 218.79 ±  84.66 ns* 
Villous width (m)  122.56 ±  39.53 125.76 ±  35.88 ns* 
Intervillous space (m)  37.68 ±  19.84 30.91 ±  34.58 ns* 
Crypt: villous ratio 0.81 ±  0.28 0.74 ±  0.34 ns* 
Goblet cells in 100 (m) villous height 4.10 ±  1.74 3.80 ±  2.01 ns* 
Vessels in the top of the villi 
 Diameter (m) 
 Wall thickness (m) 
 
26.43 ±  9.37 
2.20 ± 0.42 
 
12.29 ±  5.63 
0.56 ±  0.19 
 
< 0.001* 
< 0.001* 
Vessels in the base of the villi 
 Diameter (m) 
 Wall thickness (m) 
 
26.18 ±  16.94 
2.26 ± 0.45 
 
13.58 ±  5.88 
0.71 ± 0.31 
 
< 0.001* 
< 0.001* 
*Anova/Kruskal Wallis test;      ns = not significant 
Table 6. Other abnormalities in histopathology 
Histopathology 
Portal hypertensive 
enteropathy group  
(n = 40) 
Control group 
(n = 37) p value 
Duodenal bulb 
+ 24 8 Lymphocyte 
++ 16 29 
< 0.001* 
0 0 0 Plasma cell 
+ 40 37 
ns* 
0 0 3 
+ 39 12 
Eosinophil 
++ 1 22 
< 0.001* 
0 20 3 Polymorphonuclear cell 
+ 20 34 
< 0.001* 
0 0 0 
+ 24 9 
Stage of inflammation 
++ 16 28 
0.003* 
Descending part of duodenum 
+ 25 36 Lymphocyte 
++ 15 1 
< 0.001* 
0 0 1 Plasma cell 
+ 40 36 
ns* 
0 18 15 Eosinophil 
+ 22 22 
ns* 
0 26 33 Polymorphonuclear cell 
+ 14 4 
0.012* 
+ 25 36 Stage of inflammation 
++ 15 1 
< 0.001* 
*Chi-square/fisher test;            ns = not significant 
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Portal hypertension diffusely affects the gastro-
intestinal tract. It has been reported that besides
the stomach, the mucosa of the intestine and the colon
is also affected.26 A lot of studies revealed the close
correlation between the occurrence of enterocolopathy
and portal hypertension gastropathy.8-16 These results
were the same as the result of this study, which
revealed the occurrence of portal hypertension
gastropathy in 100% patients, enteropathy in
the duodenal bulb in 24 from 40 (60%) patients and
enteropathy in the pars descendens duodenum in 23
from 40 (57.5%) patients.
The histopathologic examination of the duodenal bulb
revealed that the villous width in the portal
hypertension group was greater than in the control
group. This finding was inline with other
studies.1-3,11,14,15 The diameter and wall thickness of
mucosa villous vessels of the duodenal bulb and
descending part of duodenum in the portal
hypertension group were greater than in the control
group. These findings were the same as in other
studies.1-3,11,14,15
The histopathologic examination of the descending
part of duodenum revealed that the villous height in
the portal hypertension group was shorter than in
the normal group. This was still questionable and could
be due to some error or other factors.
The goblet cell number in 100 mm villous height in
the duodenal bulb was higher in the portal
hypertension group than in the control group. This
finding was the same as the finding of goblet cells in
alcoholic patients, which revealed an increase of
goblet cells.27 This abnormality could be due to local
adaptation of the small intestine mucosa to pathologic
irritation, portal congestion or other factors.
The lymphocyte infiltration, stage of inflammation
and polymorphonuclear cell infiltration in the pars
descendens duodenum were more prominent in
the portal hypertension group than in the control group.
These findings could not be compared, because there
were no other studies on inflammatory cells in portal
hypertensive enteropathy. However, there was
a histological study in portal hypertensive colopathy,
which showed evidence of chronic or acute nonspe-
cific inflammation26 and another study in duodenal
mucosa in rats with portal hypertension showed an in-
crease in mast cells density compared to controls.14
All these abnormalities could be caused by the
longstandingcongestion or engorgement in the portal
system in portal hypertension.
These findings were not the same as the result in
the duodenal bulb, where we found the opposite,
the lymphocyte infiltration, stage of inflammation and
polymorphonuclear cells infiltration was more
prominent in the control group compared to the portal
hypertension group. This result needs further study.
CONCLUSION
We have found abnormalities in the mucosa in
portal hypertensive enteropathy patients including the
mucosal vessel diameter, wall thickness, goblet cells,
lymphocyte infiltration, and polymorphonuclear cells.
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